LCN2 and chronic kidney disease: Moreover, urinary NGAL measured at the onset of AKI can precisely predict persistent AKI, new-start CKD, and CKD progression in patients with AKI; therefore, it is a valuable instrument for the better assessment of AKI risk stratification (35, 36).